Sagimet Biosciences (SGMT) News Today $7.18 +0.07 (+0.94%) As of 02:32 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SGMT Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Sagimet Biosciences Inc. (NASDAQ:SGMT) Receives $25.67 Consensus Target Price from BrokeragesAugust 23 at 2:35 AM | americanbankingnews.comSagimet Biosciences Inc. (NASDAQ:SGMT) Given Average Recommendation of "Buy" by BrokeragesAugust 21, 2025 | marketbeat.comWhat is Wedbush's Estimate for SGMT Q2 Earnings?August 16, 2025 | marketbeat.comQ2 Earnings Estimate for SGMT Issued By WedbushAugust 16, 2025 | americanbankingnews.comSagimet Biosciences Enters New Sales Agreement with LeerinkAugust 15, 2025 | msn.comSagimet Biosciences Inc.: Sagimet Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate UpdatesAugust 13, 2025 | finanznachrichten.deSagimet Biosciences Reports Positive Phase 3 Results for Denifanstat in Acne and Initiates Phase 1 Trials for FASN InhibitorsAugust 13, 2025 | quiverquant.comQSagimet Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate UpdatesAugust 13, 2025 | globenewswire.comWedbush Initiates Coverage of Sagimet Biosciences (SGMT) with Outperform RecommendationAugust 12, 2025 | msn.comWedbush Begins Coverage on Sagimet Biosciences (NASDAQ:SGMT)August 12, 2025 | marketbeat.comSagimet Biosciences initiated with an Outperform at WedbushAugust 11, 2025 | msn.comWhat is HC Wainwright's Estimate for SGMT Q2 Earnings?August 11, 2025 | marketbeat.comSagimet Biosciences' (SGMT) "Buy" Rating Reaffirmed at HC WainwrightAugust 8, 2025 | marketbeat.comSagimet Biosciences (SGMT) Projected to Post Earnings on WednesdayAugust 6, 2025 | marketbeat.comSagimet Biosciences Inc. to Participate in Canaccord Genuity 45th Annual Growth Conference on August 13, 2025August 5, 2025 | quiverquant.comQSagimet Biosciences to Participate in the Canaccord Genuity 45th Annual Growth ConferenceAugust 5, 2025 | globenewswire.comSagimet Biosciences Inc. (NASDAQ:SGMT) Given Average Recommendation of "Buy" by AnalystsJuly 26, 2025 | marketbeat.comSagimet Biosciences (NASDAQ:SGMT) Coverage Initiated at Canaccord Genuity GroupJuly 25, 2025 | marketbeat.comSagimet gains as Canaccord Genuity starts with Buy on potential against MASHJuly 24, 2025 | msn.comSagimet Biosciences Inc. (NASDAQ:SGMT) Insider Eduardo Bruno Martins Sells 8,277 SharesJuly 24, 2025 | marketbeat.comInsider Selling: Sagimet Biosciences Inc. (NASDAQ:SGMT) General Counsel Sells 10,780 Shares of StockJuly 24, 2025 | marketbeat.comInsider Selling: Sagimet Biosciences Inc. (NASDAQ:SGMT) CEO Sells 65,478 Shares of StockJuly 24, 2025 | marketbeat.comInsider Selling: Sagimet Biosciences Inc. (NASDAQ:SGMT) Insider Sells 8,277 Shares of StockJuly 24, 2025 | insidertrades.comSagimet Biosciences (NASDAQ:SGMT) Trading Up 8.7% - Here's WhyJuly 23, 2025 | marketbeat.comWe Think Sagimet Biosciences (NASDAQ:SGMT) Can Afford To Drive Business GrowthJuly 16, 2025 | finance.yahoo.comSagimet Biosciences Inc. (NASDAQ:SGMT) Given Consensus Recommendation of "Buy" by AnalystsJuly 1, 2025 | marketbeat.comSGMT Sagimet Biosciences Inc. - Seeking AlphaJune 28, 2025 | seekingalpha.comSagimet Biosciences Inc News (SGMT) - Investing.comJune 27, 2025 | investing.comSagimet Biosciences Inc. (SGMT) - Yahoo FinanceJune 24, 2025 | finance.yahoo.comSagimet Biosciences Inc.June 14, 2025 | wsj.comTwo Sigma Investments LP Trims Holdings in Sagimet Biosciences Inc. (NASDAQ:SGMT)June 12, 2025 | marketbeat.comSagimet Biosciences updates executive compensationJune 12, 2025 | investing.comSagimet Biosciences to Host Virtual KOL Event, “A New Mechanism of Action in Treating Acne: Update on Positive Phase 3 Denifanstat Trial for the Treatment of Moderate to ...June 11, 2025 | morningstar.comMSagimet Biosciences to Host Virtual KOL Event, “A New Mechanism of Action in Treating Acne: Update on Positive Phase 3 Denifanstat Trial for the Treatment of Moderate to Severe Acne” on June 16, 2025June 9, 2025 | globenewswire.comSagimet Biosciences Inc. (NASDAQ:SGMT) Receives Average Recommendation of "Moderate Buy" from BrokeragesJune 6, 2025 | marketbeat.comSagimet Biosciences (NASDAQ:SGMT) Price Target Raised to $27.00 at Jones TradingJune 6, 2025 | marketbeat.comSagimet Biosciences Analyst RatingsJune 5, 2025 | benzinga.comSagimet Biosciences Shares Climb on Positive Clinical Trial Results for Acne TreatmentJune 4, 2025 | marketwatch.comSagimet Biosciences shares soar on positive acne treatment trial resultsJune 4, 2025 | ca.investing.comSagimet Biosciences Shares Surge After Promising Phase 3 Acne Drug ResultsJune 4, 2025 | msn.comSagimet climbs as acne therapy hits main goals in late-stage trial in ChinaJune 4, 2025 | msn.comSagimet: Positive China Partner Acne Vulgaris Data Bodes Well For TVB-3567June 4, 2025 | seekingalpha.comSagimet Biosciences Announces Positive Phase 3 Results for Denifanstat for the Treatment of Moderate-to-Severe Acne from Partner AscletisJune 4, 2025 | globenewswire.comMillennium Management LLC Buys 499,094 Shares of Sagimet Biosciences Inc. (NASDAQ:SGMT)June 1, 2025 | marketbeat.comSagimet Biosciences’ SWOT analysis: denifanstat’s potential in MASH treatmentMay 24, 2025 | investing.comSagimet Biosciences to Host Virtual KOL Event, “Evaluating the Synergistic Potential of a Combination of Denifanstat and Resmetirom for the Treatment of Metabolic Dysfunction ...May 24, 2025 | morningstar.comMSagimet Biosciences to Host Virtual KOL Event, “Evaluating the Synergistic Potential of a Combination of Denifanstat and Resmetirom for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH)” on May 29, 2025May 22, 2025 | globenewswire.comSagimet Biosciences (SGMT) Expected to Announce Earnings on WednesdayMay 16, 2025 | marketbeat.comSagimet Biosciences Inc. (NASDAQ:SGMT) Shares Purchased by Bridgeway Capital Management LLCMay 13, 2025 | marketbeat.comRenaissance Technologies LLC Sells 220,300 Shares of Sagimet Biosciences Inc. (NASDAQ:SGMT)May 10, 2025 | marketbeat.com Get Sagimet Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SGMT and its competitors with MarketBeat's FREE daily newsletter. Email Address SGMT Media Mentions By Week SGMT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SGMT News Sentiment▼0.260.71▲Average Medical News Sentiment SGMT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SGMT Articles This Week▼22▲SGMT Articles Average Week Get Sagimet Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SGMT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Oric Pharmaceuticals News Today Iovance Biotherapeutics News Today Sionna Therapeutics News Today Trevi Therapeutics News Today Urogen Pharma News Today Cronos Group News Today Immunome News Today uniQure News Today Precigen News Today Akebia Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SGMT) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sagimet Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sagimet Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access